Qizhi Tang

Title: Qizhi Tang: Innovator in Immunology and Diabetes Treatment

Introduction

Qizhi Tang is a prominent inventor based in San Francisco, CA, known for his significant contributions to the fields of immunology and diabetes treatment. With a total of 4 patents, his work focuses on innovative solutions for immune diseases and conditions related to diabetes.

Latest Patents

Among his latest patents is the invention titled "Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods of use thereof to treat CD2-mediated immune diseases, disorders or conditions." This invention provides LFA3 polypeptide molecules, including variant LFA3 fusion polypeptide molecules, along with methods for their use. Another notable patent is "Preservation of pancreatic islet grafts in the extrahepatic space," which outlines methods and compositions for treating diabetes mellitus through the co-transplantation of insulin-producing cells and cells derived from the parathyroid gland.

Career Highlights

Qizhi Tang has worked with esteemed institutions such as the University of California and the United States Government as represented by the Department of Veterans Affairs. His research has led to advancements in the treatment of immune-related diseases and diabetes, showcasing his dedication to improving patient outcomes.

Collaborations

Throughout his career, Qizhi Tang has collaborated with notable colleagues, including Jeffrey A. Bluestone and Emma Masteller. These partnerships have contributed to the success of his research and the development of his patented inventions.

Conclusion

Qizhi Tang's innovative work in immunology and diabetes treatment highlights his role as a leading inventor in these critical fields. His patents reflect a commitment to advancing medical science and improving the lives of patients suffering from immune diseases and diabetes.